ConductScience.org, home

Paper1676367

A single dose study of the effects of fenoldopam and enalapril in mild hypertension.

MacDonald TM and 3 others. Eur J Clin Pharmacol, 1991. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. A single dose study of the effects of fenoldopam and enalapril in mild hypertension. Papers, record 1676367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1676367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A single dose study of the effects of fenoldopam and enalapril in mild hypertension.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.15
iCite
Revised in PubMed
2019-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1MacDonald TMT M
2Jeffrey RFR F
3Freestone SS
4Lee MRM R

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineMajor topic
Dopamine AgentsMajor topic
EnalaprilMajor topic
HypertensionMajor topic
Adult
Blood Pressure
Creatinine
Double-Blind Method
Drug Synergism
Drug Therapy, Combination
Fenoldopam
Humans
Middle Aged
Natriuresis
Posture
Pulse

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14311082Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.J Clin Endocrinol Metab1969https://conductscience.org/library/papers/4311082PubMed
26127401Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.J Pharmacol Exp Ther1982https://conductscience.org/library/papers/6127401PubMed
33555588Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3555588PubMed
46143625Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.Circulation1984https://conductscience.org/library/papers/6143625PubMed
52898985The role of alpha-adrenoceptor blockade in the antihypertensive effects of fenoldopam in humans.Clin Pharmacol Ther1988https://conductscience.org/library/papers/2898985PubMed
62868748Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2868748PubMed
72885268Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.Hypertension1987https://conductscience.org/library/papers/2885268PubMed
82878679The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2878679PubMed
91970961A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart disease.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/1970961PubMed
106130004Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526.Fed Proc1983https://conductscience.org/library/papers/6130004PubMed
116150942Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.J Clin Invest1984https://conductscience.org/library/papers/6150942PubMed
122580182Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.J Cardiovasc Pharmacol1985https://conductscience.org/library/papers/2580182PubMed
132863295Hemodynamic effects of an oral dopamine receptor agonist (fenoldopam) in patients with congestive heart failure.J Am Coll Cardiol1985https://conductscience.org/library/papers/2863295PubMed
142890447Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.Circulation1987https://conductscience.org/library/papers/2890447PubMed
152880687The effect of acetaminophen on the disposition of fenoldopam: competition for sulfation.Clin Pharmacol Ther1987https://conductscience.org/library/papers/2880687PubMed
162897206Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients.Br J Clin Pharmacol1988https://conductscience.org/library/papers/2897206PubMed
176136359A new oral renal vasodilator, fenoldopam.Clin Pharmacol Ther1983https://conductscience.org/library/papers/6136359PubMed
182895118The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man.J Clin Endocrinol Metab1988https://conductscience.org/library/papers/2895118PubMed
192894216Effects of fenoldopam, a specific dopamine receptor agonist, on blood pressure and left ventricular function in systemic hypertension.Br J Clin Pharmacol1987https://conductscience.org/library/papers/2894216PubMed
202896014Continuous intragastric delivery of fenoldopam: relationship between plasma concentration and effects on renal function.Br J Clin Pharmacol1988https://conductscience.org/library/papers/2896014PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42589441Dopamine D1-like and Angiotensin II Type 1 Receptors Counter-Regulate Autophagy and Cell Proliferation in Rat Embryonic Thoracic Vascular Smooth Muscle Cells.Int J Mol Sci2026https://conductscience.org/library/papers/42589441PubMed
9339965Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.Drugs1997https://conductscience.org/library/papers/9339965PubMed
8354016Pharmacokinetic drug interactions with ACE inhibitors.Clin Pharmacokinet1993https://conductscience.org/library/papers/8354016PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1676367

GET https://conductscience.org/api/papers/v1/1676367/authors